DR. MATTHEW PLYMYER M.D. NPI 1043265051

NPI Details

DR. Matthew Plymyer, M.D. is an anatomic pathology and clinical pathology pathology in Morrisville, NC with 39 years of experience. The provider is a pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease. DR. Matthew Plymyer, M.D. NPI is 1043265051. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL COLLEGE OF PENNSYLVANIA
Graduation Year:1987

The provider's business location address is:

200 PERIMETER PARK DR STE C
MORRISVILLE, NC
ZIP 27560-714
Phone: (919) 589-2520
Fax: (984) 239-2619

The NPI 1043265051 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
• Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
• Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
• Pap test (HCPCS:88141)
• Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician (HCPCS:G0141)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Measurement of rna of bacteria in vaginal fluid specimen (HCPCS:81513)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only (HCPCS:87625)

The enumeration date for this NPI number is 5/24/2006 and was last updated on 8/5/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: